Watch the video interview with Sijme Zeilemaker from LSX World Congress in London here:
The content of BioStock's news and analysis is independent, but BioStock's operations are to some extent financed by companies in the industry. This post refers to a company from which BioStock has received funding.
|
Published February 5, 2020
Immunicum rushed ahead of MERECA update
Immuno-oncology company Immunicum's stock price took a big step up on Tuesday. At its peak, the stock rose just over 35 percent and closed the trading day up about 27 percent. The rush came after an abstract of the MERECA study was published online, ahead of Thursday's upcoming presentation of the study results at ASCO-SITC in Orlando. BioStock had a chat with Sijme Zeilemaker, COO Immunicum, on site in London during the LSX World Congress.